Díez-Villanueva Pablo, Jiménez-Méndez César, Pérez-Rivera Ángel, Barge Caballero Eduardo, López Javier, Ortiz Carolina, Bonanad Clara, Goirigolzarri Josebe, Esteban Fernández Alberto, Cobo Marta, Montes Nuria, Ariza-Solé Albert, Martínez-Sellés Manuel, Alfonso Fernando
Cardiology Deparment, Hospital Universitario de la Princesa, Madrid, Spain.
Cardiology Deparment, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Eur J Intern Med. 2025 Feb;132:90-96. doi: 10.1016/j.ejim.2024.12.001. Epub 2024 Dec 7.
Chronic kidney disease (CKD) and frailty are often present in older patients with heart failure (HF). Our aim was to evaluate the association of CKD and frailty in one-year mortality in a cohort of older (≥75 years) outpatients with HF METHODS: Our data come from the FRAGIC study ("impacto de la FRAGilidad y otros síndromes Geriátricos en el manejo clínico y pronóstico del paciente anciano ambulatorio con Insuficiencia Cardíaca"), a multicenter prospective registry conducted in 16 cardiology services in Spain which included ≥75 years outpatients with HF. Renal function was assessed according to CKD-EPI formula. A comprehensive geriatric assessment was performed and frailty was identified according to visual mobility scale (frail if VMS≥2). Survival rates were analyzed by Cox regression model.
We included 499 patients, mean age 81.4 ± 4.3 years, 38 % women. Mean estimated glomerular filtration rate (eGFR) was 52.1 ± 17.5 ml/min/1.72 m. Patients were classified in normal renal function (eGFR≥60 ml/min/1.72m, 182 patients, 36 %), moderately impaired (eGFR 30-59 ml/min/1.72m, 261 patients, 52.7 %) and severely impaired (eGFR<30 ml/min/1.72m, 56 patients, 11.3 %). Patients with severe CKD were older, more often female, and presented a worse clinical profile, with higher comorbidity burden and frailty. After a median follow up of 371 days, 58 patients (11.6 %) died. Mortality was higher in patients with worse renal function (8.8 %, 11 % and 21 % according to renal function subgroups, respectively, p = 0.036) and frailty in the univariate analysis. However, only frailty, according to VMS, but not severe renal dysfunction, was independently associated with one year mortality.
Most HF patients≥75 years have renal dysfunction. CKD is a marker of worse prognosis in elderly patients with chronic HF, but it does not independently associate one-year mortality in the presence of frailty.
慢性肾脏病(CKD)和衰弱在老年心力衰竭(HF)患者中常同时存在。我们的目的是评估在一组年龄较大(≥75岁)的门诊HF患者中,CKD和衰弱与一年死亡率之间的关联。方法:我们的数据来自FRAGIC研究(“老年门诊心力衰竭患者中衰弱及其他老年综合征对临床管理和预后的影响”),这是一项在西班牙16个心脏病科进行的多中心前瞻性登记研究,纳入了年龄≥75岁的门诊HF患者。根据CKD-EPI公式评估肾功能。进行了全面的老年综合评估,并根据视觉运动量表确定衰弱情况(如果VMS≥2则为衰弱)。通过Cox回归模型分析生存率。
我们纳入了499例患者,平均年龄81.4±4.3岁,女性占38%。平均估计肾小球滤过率(eGFR)为52.1±17.5 ml/min/1.72 m²。患者被分类为肾功能正常(eGFR≥60 ml/min/1.72m²,182例患者,36%)、中度受损(eGFR 30 - 59 ml/min/1.72m²,261例患者,52.7%)和严重受损(eGFR<30 ml/min/1.72m²,56例患者,11.3%)。重度CKD患者年龄更大,女性更常见,临床情况更差,合并症负担更高且衰弱程度更高。在中位随访371天后,58例患者(11.6%)死亡。在单因素分析中,肾功能较差的患者死亡率更高(根据肾功能亚组分别为8.8%、11%和21%,p = 0.036),衰弱患者死亡率也更高。然而,仅根据VMS判断的衰弱,而非严重肾功能不全,与一年死亡率独立相关。
大多数≥75岁的HF患者存在肾功能不全。CKD是老年慢性HF患者预后较差的一个标志,但在存在衰弱的情况下,它与一年死亡率并无独立关联。